Within AMKL, transient abnormal myelopoiesis (TAM) and myeloid leukemia associated with DS (ML-DS) show higher frequencies of CD34+/CD117+ leukemic blasts compared to other AMKL subgroups. This evidence concerns the gene CD34 and Dravet syndrome.